Letrozol
Showing 1 - 18 of 18
Infertility, Female Trial (Letrozol (Femara, Novartis), Letrozol (Femara, Novartis) combined with Metformin (Cidophage 500 mg,
Not yet recruiting
- Infertility, Female
- Letrozol (Femara, Novartis)
- +3 more
- (no location specified)
May 2, 2022
Early-Stage Breast Carcinoma, Hormone Receptor Positive Tumor Trial in Stockholm (Tamoxifen or Aromatase Inhibitor or Aromatase
Active, not recruiting
- Early-Stage Breast Carcinoma
- Hormone Receptor Positive Tumor
- Tamoxifen or Aromatase Inhibitor or Aromatase Inhibitor + goserelin
- Palbociclib
-
Stockholm, SwedenDepartment of Oncology, Karolinska University Hospital
Jul 5, 2020
Pregnancy Outcome, Time-to-Pregnancy Trial in Shanghai (undergoing PGT)
Not yet recruiting
- Pregnancy Outcome
- Time-to-Pregnancy
- undergoing PGT
-
Shanghai, ChinaShanghai first Maternity and Infant health hospital, Tong Ji Uni
Jul 11, 2022
Cancer Related Fatigue Trial in Stavanger (REBECCA-assisted intervention)
Recruiting
- Cancer Related Fatigue
- REBECCA-assisted intervention
-
Stavanger, Rogaland, NorwayStavanger University Hospital
Nov 6, 2023
Breast Cancer Trial in Portugal, Spain (Pre treatment Recurrence Score:18-25 Letrozole + Palbociclib, Pre treatment Recurrence
Completed
- Breast Cancer
- Pre treatment Recurrence Score:18-25 Letrozole + Palbociclib
- Pre treatment Recurrence Score:26-100 Letrozole + Palbociclib
-
Lisboa, Portugal
- +17 more
Nov 25, 2020
EMBRYO IMPLANTATION Trial in Mansoura (Letrozole 2.5Mg Tablet, Gonadotropins, endometrial sample in the pretreatment cycle)
Unknown status
- EMBRYO IMPLANTATION
- Letrozole 2.5Mg Tablet
- +2 more
-
Mansoura, EgyptMansoura University
Dec 13, 2019
Induction of Ovulation Trial in Cairo (group A 2.5 mg letrozole oral tablets, laparoscopic ovarian drilling)
Unknown status
- Induction of Ovulation
- group A 2.5 mg letrozole oral tablets
- laparoscopic ovarian drilling
-
Cairo, EgyptAin shams university maternity hospital
Sep 7, 2018
Hormone Dependent Tumors, Breast Cancer Female Trial in Lisbon (Aromatase Inhibitors)
Unknown status
- Hormone Dependent Neoplasms
- Breast Cancer Female
- Aromatase Inhibitors
-
Lisbon, PortugalHospital São Francisco Xavier
Dec 2, 2017
is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer
Unknown status
- is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients.
-
Erlangen, Bavaria, GermanyFrauenklinik University Hospital
Jul 24, 2013
Breast Cancer Trial in Shanghai (Capecitabine, aromatase Inhibitors (AIs))
Unknown status
- Breast Cancer
- Capecitabine
- aromatase Inhibitors (AIs)
-
Shanghai, Shanghai, ChinaFUSCC
Aug 14, 2013
Breast Cancer Trial in Herlev (DC vaccine, aromatase inhibitor)
Withdrawn
- Breast Cancer
- DC vaccine
- aromatase inhibitor
-
Herlev, DenmarkDepartment of Oncology, Copenhagen University Hospital, Herlev
May 30, 2012
Collaborative Seamless Care in Oncology : Measure and Reinforce
Unknown status
- Cancer
-
Lausanne, Vaud, SwitzerlandPoliclinique Médicale Universitaire and Centre pluridisciplinair
Jul 16, 2012
Ovarian Response Trial (letrozole , oxytocin,hCG,clomiphene citrate)
Completed
- Ovarian Response
- letrozole , oxytocin,hCG,clomiphene citrate
- (no location specified)
Feb 13, 2009